Knappertz Volker
- SEC CIK
- 0001754122
No open-market purchases or sales filed in the past year.
Current role at each company
- AUPH Aurinia Pharmaceuticals Inc.EVP, Research and Developmentas of Feb 29, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Knappertz Volker as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 29, 2024 (view filing) | Feb 27 | 2 days | Knappertz VolkerEVP, Research and Development | SSale | −4.93K | $6.10 | −$30.1K | −1.5%319.1K after | |
| Feb 22, 2024 (view filing) | Feb 20 | 2 days | Knappertz VolkerEVP, Research and Development | SSale | −25.1K | $5.48 | −$137.8K | −7.2%324.1K after |